Cytek IPO Presentation Deck

1. Cytek' FSP Platform versus Other Technologies Conventional Flow Cytometry Biomarkers / Parameters (>40 biomarkers)¹ Sensitivity (nanoparticle detection) Throughput (>30K cell/second) Footprint (<150K cm³) Sorting Capability Cost Performance² CYTEK TRANSCEND THE CONVENTIONAL X X Spectral Flow Cytometry Xx X X X X Based on peer-reviewed publications Cost-to-Performance reflects performance based on accessible biomarkers, sensitivity, throughput and sorting capabilities, relative to costs associated with instruments, consumables, time, labor and ability to upgrade over time Mass Cytometry X X X X X CYTEK 16

View entire presentation